Seungjae Baek

7PUBLICATIONS
22CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPharmacogenomicsBehavioural epidemiologyEpidemiological modellingAcoustics and noise control (excl. architectural acoustics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 25, 2023
The Novel Tetra-Specific Drug C-192, Conjugated Using UniStac, Alleviates Non-Alcoholic Steatohepatitis in an MCD Diet-Induced Mouse Model.

Jihye Kim, Nakho Chang, Yunki Kim

|Jun 13, 2023
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.

Wonjung Shin, Marcus Hompesch, JinHee Byeon

|Apr 04, 2023
Efficacy and safety of once-weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE-D, AMPLITUDE-L and AMPLITUDE-S randomized controlled trials.

Vanita R Aroda, Juan Pablo Frias, Linong Ji

|Feb 21, 2023
Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial.

Hertzel C Gerstein, Zhuoru Li, Chinthanie Ramasundarahettige

|Jun 07, 2022
Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial.

Juan Pablo Frias, JaeDuk Choi, Julio Rosenstock

|Nov 15, 2021
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial.

Carolyn S P Lam, Chinthanie Ramasundarahettige, Kelley R H Branch

Pageof 2

Frequent Collaborators

2 joint publications

Juan Pablo Frias

2 joint publications

Carolyn S P Lam

2 joint publications

Kelley R H Branch

2 joint publications

Naveed Sattar